Mumps Market Expansion Projected to Gain an Uptick During 2017 - 2025

Mumps is a contagious disease typically affecting children and caused by the mumps virus. The characteristic of this disease is the initial onset of headache, loss of appetite, muscle aches, tiredness and fever followed by the typical swelling of one or more salivary glands. The disease is transmitted from one person to the other through saliva and/or droplets. Although the symptoms vanish within few days of infection and are usually mild requiring only symptomatic pain relief, complications can occur in rare cases, which requires immediate medical attention and treatment.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/13501


Complications can involve infection in testicles (in post-pubertal males), ovaries, prostate gland, thyroid gland, and pancreas. Brain infection is believed to occur in only one in 10,000 cases, but it often leads to death. Although the mumps virus infects mostly children aged five to ten, it can infect adults as well and when it does, it is more likely that the complications are serious. These could be a loss of hearing and loss of fertility. For this reason, the prevention of the disease gets precedence over its cure. Mumps was a common viral disease until the mumps vaccine was launched in 1967. Before the launch of the vaccine, greater than 200,000 cases of mumps occurred each year in the United States.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/13501

Presently, however, the availability of the vaccine has led to a decrease in the number of cases to fewer than 1,000 a year, and epidemics have also become fairly rare. According to the WHO, in the countries where large-scale immunization against mumps has been applied, the incidence of the disease has dropped radically. However, outbreaks do continue to occur and some immunized individuals, who have been in very close contact with someone who is infected, can still contract the disease. Yet, vaccination is highly crucial in protection against the infectious disease. For instance, in the U.S., in August 2016, dozens were diagnosed with mumps in New York City, and subsequently, greater than 400 people were affected with the virus across Arkansas.

Buy Now: You can now buy a single user license of the report @ http://www.persistencemarketresearch.com/checkout/13501

The mumps market has been segmented on the basis of type of therapy, end-user and geography. Based on type of therapy, the mumps market has been segmented into preventive and curative therapies. The preventive therapy includes the Measles Mumps Rubella (MMR) vaccine, Measles, Mumps, Rubella, Varicella (MMRV) vaccine and single-unit mumps vaccine. The curative therapies segment includes analgesics for the basic symptom of headache and pain in mumps and antibiotic and anti-inflammatory agents to manage the complications arising from mumps infection.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.